1Nancollas GH, Tang R, Phipps RJ, et al. Novel insights into actions of bisphosphonates on bone:differences in interactions with hydroxyapatite [J]. Bone,2006 ;38:617-27.
2Dunford JE, Thompson K, Coxon FP, et al. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates [J]. J Pharmacol Exp Ther,2001 ;296:235-42.
3Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis[J]. N Engl J Med,2007 ;356 : 1809-22.
9Klingberg E, Geijer M, G~thlin J, et ai. Vertebral frac- tures in ankylosing spondylitis are associated with lower bone mineral density in both central and peripheral skel- eton[J]. J Rheumatol,2012,39(10) : 1987-1995.
10Neumann A,Wuer{el J,Hunold P. Wedge-shaped verte bra-an unusual complication of the pathomechanical cas- cade of ankylosing spondylitis-osteoporosis-vertebral body fraction[J]. Rofo, 2011,183 (6) : 564-566.
